newsfilter
← Latest News
PR Newswire·

MRIdian Clinical Studies and Initial MRIdian A3i Clinical Experience to be Highlighted at ASTRO 2022

Clinical outcome oral presentations on SMART Pancreas and MIRAGE prostate studies DENVER, Oct. 19, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ:VRAY) today announced that the company's MRIdian® MRI-Guided